(Q37786513)

23 August 2017

title

Clinically amyopathic dermatomyositis (English)

1 reference

23 August 2017

0 references

Shinji Sato

1

1 reference

23 August 2017

Masataka Kuwana

2

1 reference

23 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20827200

9 July 2024

publication date

1 November 2010

1 reference

full work available at URL

23 August 2017

https://journals.lww.com/10.1097/BOR.0b013e32833f1987

1 reference

https://api.crossref.org/works/10.1097/BOR.0B013E32833F1987

Current Opinion in Rheumatology

9 July 2024

published in

1 reference

23 August 2017

volume

22

1 reference

23 August 2017

issue

6

1 reference

23 August 2017

page(s)

639-643

1 reference

Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis siné myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness?

23 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1097/BOR.0B013E32833F1987

Clinically amyopathic dermatomyositis: what can we now tell our patients?

9 July 2024

4

1 reference

https://api.crossref.org/works/10.1097/BOR.0B013E32833F1987

Amyopathic dermatomyositis or dermatomyositis-like skin disease: retrospective review of 16 cases with amyopathic dermatomyositis

9 July 2024

5

1 reference

https://api.crossref.org/works/10.1097/BOR.0B013E32833F1987

Polymyositis and dermatomyositis (first of two parts)

9 July 2024

6

1 reference

https://api.crossref.org/works/10.1097/BOR.0B013E32833F1987

Number, characteristics, and classification of patients with dermatomyositis seen by dermatology and rheumatology departments at a large tertiary medical center

9 July 2024

7

1 reference

https://api.crossref.org/works/10.1097/BOR.0B013E32833F1987

Incidence of dermatomyositis and clinically amyopathic dermatomyositis: a population-based study in Olmsted County, Minnesota

9 July 2024

8

1 reference

https://api.crossref.org/works/10.1097/BOR.0B013E32833F1987

A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies

9 July 2024

9

1 reference

https://api.crossref.org/works/10.1097/BOR.0B013E32833F1987

Activity of certain drugs in inducing of inflammatory myopathies with cutaneous manifestations

9 July 2024

10

1 reference

https://api.crossref.org/works/10.1097/BOR.0B013E32833F1987

Amyopathic dermatomyositis resembling stasis dermatitis

9 July 2024

11

1 reference

https://api.crossref.org/works/10.1097/BOR.0B013E32833F1987

Simvastatin-induced amyopathic dermatomyositis.

9 July 2024

12

1 reference

https://api.crossref.org/works/10.1097/BOR.0B013E32833F1987

Undescribed case of necrotic ulcerative amyopathic dermatomyositis in bone metastatic breast cancer

9 July 2024

14

1 reference

https://api.crossref.org/works/10.1097/BOR.0B013E32833F1987

Amyopathic dermatomyositis associated with esophageal cancer

9 July 2024

15

1 reference

https://api.crossref.org/works/10.1097/BOR.0B013E32833F1987

A rare lymphoma in a patient with amyopathic dermatomyositis

9 July 2024

16

1 reference

https://api.crossref.org/works/10.1097/BOR.0B013E32833F1987

Skin manifestations of internal disease

9 July 2024

17

1 reference

https://api.crossref.org/works/10.1097/BOR.0B013E32833F1987

Factors associated with underlying malignancy in a retrospective cohort of 121 patients with dermatomyositis

9 July 2024

18

1 reference

https://api.crossref.org/works/10.1097/BOR.0B013E32833F1987

Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis

9 July 2024

19

1 reference

https://api.crossref.org/works/10.1097/BOR.0B013E32833F1987

Clinical differences between interstitial lung disease associated with clinically amyopathic dermatomyositis and classic dermatomyositis.

9 July 2024

20

1 reference

https://api.crossref.org/works/10.1097/BOR.0B013E32833F1987

Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study

9 July 2024

21

1 reference

https://api.crossref.org/works/10.1097/BOR.0B013E32833F1987

Intravenous cyclophosphamide therapy for progressive interstitial pneumonia in patients with polymyositis/dermatomyositis.

9 July 2024

24

1 reference

https://api.crossref.org/works/10.1097/BOR.0B013E32833F1987

Successful treatment with tacrolimus of progressive interstitial pneumonia associated with amyopathic dermatomyositis refractory to cyclosporine

9 July 2024

25

1 reference

https://api.crossref.org/works/10.1097/BOR.0B013E32833F1987

Rapidly progressive interstitial pneumonia associated with clinically amyopathic dermatomyositis successfully treated with polymyxin B-immobilized fiber column hemoperfusion

9 July 2024

26

1 reference

https://api.crossref.org/works/10.1097/BOR.0B013E32833F1987

Intravenous immunoglobulin therapy for refractory interstitial lung disease associated with polymyositis/dermatomyositis

9 July 2024

27

1 reference

https://api.crossref.org/works/10.1097/BOR.0B013E32833F1987

Increased ferritin predicts development and severity of acute interstitial lung disease as a complication of dermatomyositis

9 July 2024

28

1 reference

https://api.crossref.org/works/10.1097/BOR.0B013E32833F1987

Pneumomediastinum and subcutaneous emphysema secondary to amyopathic dermatomyositis with cryptogenic organizing pneumonia in invasive breast cancer: a case report and review of literature

9 July 2024

29

1 reference

https://api.crossref.org/works/10.1097/BOR.0B013E32833F1987

Pneumomediastinum in interstitial lung disease associated with dermatomyositis and polymyositis

9 July 2024

30

1 reference

https://api.crossref.org/works/10.1097/BOR.0B013E32833F1987

Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression

9 July 2024

31

1 reference

https://api.crossref.org/works/10.1097/BOR.0B013E32833F1987

A novel autoantibody to a 155-kd protein is associated with dermatomyositis

9 July 2024

32

1 reference

https://api.crossref.org/works/10.1097/BOR.0B013E32833F1987

Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis.

9 July 2024

33

1 reference

https://api.crossref.org/works/10.1097/BOR.0B013E32833F1987

Association of distinct clinical subsets with myositis-specific autoantibodies towards anti-155/140-kDa polypeptides, anti-140-kDa polypeptides, and anti-aminoacyl tRNA synthetases in Japanese patients with dermatomyositis: a single-centre, cross-se

9 July 2024

34

1 reference

https://api.crossref.org/works/10.1097/BOR.0B013E32833F1987

Identification of a novel autoantibody directed against small ubiquitin-like modifier activating enzyme in dermatomyositis

9 July 2024

35

1 reference

https://api.crossref.org/works/10.1097/BOR.0B013E32833F1987

RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung disease

9 July 2024

36

1 reference

https://api.crossref.org/works/10.1097/BOR.0B013E32833F1987

The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody

9 July 2024

37

1 reference

https://api.crossref.org/works/10.1097/BOR.0B013E32833F1987

Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses

9 July 2024

38

1 reference

https://api.crossref.org/works/10.1097/BOR.0B013E32833F1987

A systematic review of juvenile-onset clinically amyopathic dermatomyositis

9 July 2024

39

1 reference

https://api.crossref.org/works/10.1097/BOR.0B013E32833F1987

Amyopathic dermatomyositis: retrospective review of 37 cases.

9 July 2024

40

1 reference

https://api.crossref.org/works/10.1097/BOR.0B013E32833F1987

Amyopathic juvenile dermatomyositis: a case presentation.

9 July 2024

42

1 reference

https://api.crossref.org/works/10.1097/BOR.0B013E32833F1987

Juvenile-onset clinically amyopathic dermatomyositis: an overview of recent progress in diagnosis and management

9 July 2024

43

1 reference

https://api.crossref.org/works/10.1097/BOR.0B013E32833F1987

Juvenile amyopathic dermatomyositis complicated by progressive interstitial pneumonia

9 July 2024

44

1 reference

https://api.crossref.org/works/10.1097/BOR.0B013E32833F1987

Interstitial lung disease associated with juvenile dermatomyositis: clinical features and efficacy of cyclosporin A.

9 July 2024

45

1 reference

https://api.crossref.org/works/10.1097/BOR.0B013E32833F1987

9 July 2024

Identifiers

1 reference

23 August 2017

1 reference